允许性低血压与传统复苏策略在成人创伤失血性休克中的比较:随机对照试验的系统评价与Meta分析
该系统评价与Meta分析检索MEDLINE和EMBASE至2017年5月,纳入5项随机对照试验共1158例成人创伤失血性休克患者,比较允许性低血压(收缩压50-70 mmHg或平均动脉压≥50 mmHg)与传统复苏(收缩压65-100 mmHg或平均动脉压≥65 mmHg)。主要终点为30天或住院死亡率,合并OR为0.70(95%CI 0.53-0.92),提示允许性低血压有生存获益;允许性低血压组接受更少血制品且估计失血量更少。但多数研究把握度不足,证据质量差至中等,作者认为需要高质量、把握度充分的研究。
要点
- 成人创伤失血性休克中,允许性低血压组(收缩压50-70 mmHg或平均动脉压≥50 mmHg)较传统复苏组(收缩压65-100 mmHg或平均动脉压≥65 mmHg)30天或住院死亡率合并OR 0.70(95%CI 0.53-0.92)。
- 允许性低血压组接受更少血制品,且估计失血量更少。
- 5项随机试验中4项提示允许性低血压有生存获益,但其中3项把握度不足以达到统计学显著性。
- 研究质量差至中等,原因为方案报告不佳和缺乏盲法。
- 作者认为允许性低血压可能提供生存获益并减少失血和血制品使用,但多数研究把握度不足,需要高质量、把握度充分的研究。
适用人群与场景
- 成人创伤失血性休克患者,纳入术前和术中复苏策略。
- 5项试验中2项仅纳入穿透伤患者,其余3项 additionally 纳入钝性伤患者。
处置流程与药物剂量
- 允许性低血压组血压目标:收缩压50 mmHg至70 mmHg,或平均动脉压≥50 mmHg。
- 传统复苏组血压目标:收缩压65 mmHg至100 mmHg,或平均动脉压≥65 mmHg。
研究设计与关键结果
- 系统评价与Meta分析,检索MEDLINE和EMBASE自建库至2017年5月,筛选722篇摘要,最终纳入5项随机对照试验共1158例患者。
- 主要终点30天或住院死亡率合并OR 0.70(95%CI 0.53-0.92),提示允许性低血压有生存获益。
- 允许性低血压组接受更少血制品,估计失血量更少。
- 4项试验提示允许性低血压有30天或住院死亡率生存获益,但其中3项把握度不足以发现统计学显著性。
- 研究质量差至中等,原因为方案报告不佳和缺乏盲法。
证据类型、等级与局限
- 证据类型:随机对照试验的系统评价与Meta分析。
- 证据等级:Systematic Review, level II(PROSPERO注册号CRD42017070526)。
- 局限:研究质量差至中等,原因为方案报告不佳和缺乏盲法;多数研究把握度不足;作者结论指出需要高质量、把握度充分的研究。
对床旁实践的改变
- 作者认为允许性低血压可能为出血性损伤患者提供优于传统复苏的生存获益,并可能减少失血和血制品使用。
- 作者指出多数研究把握度不足,反映需要高质量、把握度充分的研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Aggressive fluid resuscitation in trauma promotes deleterious effects such as clot disruption, dilutional coagulopathy and hypothermia. Animal studies suggest that permissive hypotension maintains appropriate organ perfusion, reduces bleeding and improves mortality. This review assesses the efficacy and safety of permissive hypotension in adult trauma patients with hemorrhagic shock.
METHODS: We searched the MEDLINE and EMBASE databases from inception to May 2017 for randomized controlled trials comparing permissive hypotension vs. conventional resuscitation following traumatic injury. We included preoperative and intraoperative resuscitation strategies. The primary outcome was 30-day or in-hospital mortality. Secondary outcomes included blood product utilization, estimated blood loss and in-hospital complications. Pooling was performed with a random-effects model.
RESULTS: We screened 722 abstracts, from which five randomized trials evaluating 1,158 patients were included. Blood pressure targets in the intervention arms varied from systolic BP 50 mm Hg to 70 mm Hg or mean arterial pressure of 50 mm Hg or higher as compared to systolic BP 65 mm Hg to 100 mm Hg or mean arterial pressure of 65 or higher in the control arms. Two studies evaluated only patients with penetrating injury while the remaining three additionally included blunt injuries. Four trials suggested a survival benefit for 30-day or in-hospital mortality with hypotensive resuscitation, although three studies were insufficiently powered to find statistical significance. Studies were of poor to moderate quality due to poor protocol reporting and lack of blinding. The pooled odds ratio was 0.70 (95% confidence interval, 0.53-0.92), suggesting a survival benefit for permissive hypotension. Those patients received fewer blood products and had lesser estimated blood loss.
CONCLUSION: Permissive hypotension may offer a survival benefit over conventional resuscitation for patients with hemorrhagic injury. It may additionally reduce blood loss and blood product utilization. However, the majority of studies were underpowered, thus reflecting a need for high quality, adequately powered trials.
PROSPERO REGISTRATION: Systematic Review, level II.CRD42017070526.
参考来源
- Tran A, Yates J, Lau A, et al. Permissive hypotension versus conventional resuscitation strategies in adult trauma patients with hemorrhagic shock: A systematic review and meta-analysis of randomized controlled trials. J Trauma Acute Care Surg. 2018. PMID: 29370058. doi:10.1097/TA.0000000000001816
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。